Momenta: The perfect Massachusetts success story
News | 18 May 2012
A hit product propelled this maker of generic drugs from a money-losing operation to the top of the Globe 100 list. By Robert Weisman Craig A. Wheeler, chief executive of Momenta Pharmaceuticals Inc. Momenta Pharmaceuticals Inc. has discovered that ...
Click on the link to read the full article at Boston Globe
(This link will open in a new window)
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
